Logos Global Management LP Pliant Therapeutics, Inc. Transaction History

Logos Global Management LP

  • $756 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021
SELL
$24.52 - $40.23 $1.87 Million - $3.07 Million
-76,426 Closed
0 $0
Q4 2020

Feb 16, 2021
SELL
$19.89 - $32.99 $1.2 Million - $1.99 Million
-60,289 Reduced 44.1%
76,426 $1.74 Million
Q3 2020

Nov 16, 2020
SELL
$21.54 - $29.53 $6.89 Million - $9.44 Million
-319,711 Reduced 70.05%
136,715 $3.1 Million
Q2 2020

Aug 14, 2020
BUY
$21.3 - $35.26 $9.72 Million - $16.1 Million
456,426 New
456,426 $14.6 Million

Others Institutions Holding PLRX

# of Institutions
168
Shares Held
63.2M
Call Options Held
245K
Put Options Held
373K
View Full List

About PLIANT THERAPEUTICS, INC.

PLRX Quotes by TradingView
  • Ticker PLRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,682,000
  • Market Cap $600M
  • Description
  • Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...
More about PLRX
Track This Portfolio

Track Logos Global Management LP Portfolio

Follow Logos Global Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Logos Global Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Logos Global Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email